The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1471
ISSUE1471
June 22, 2015
Droxidopa (Northera) for Neurogenic Orthostatic Hypotension
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Droxidopa (Northera) for Neurogenic Orthostatic Hypotension
June 22, 2015 (Issue: 1471)
The FDA has approved droxidopa (Northera –
Lundbeck) for oral treatment of adults with symptomatic
neurogenic orthostatic hypotension (NOH) caused
by primary autonomic failure (Parkinson's disease,
multiple system atrophy, or pure autonomic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.